The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paisansinsup, T.
Right arrow Articles by David, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paisansinsup, T.
Right arrow Articles by David, C. S.
The Journal of Immunology, 2001, 167: 4083-4090.
Copyright © 2001 by The American Association of Immunologists

HLA-DR Modulates Autoantibody Repertoire, But Not Mortality, in a Humanized Mouse Model of Systemic Lupus Erythematosus1

Tawatchai Paisansinsup, Abbe N. Vallejo, Harvinder Luthra and Chella S. David2

Division of Rheumatology, Departments of Medicine and Immunology, Mayo Clinic, Rochester, MN 55905

To evaluate the disease-modulating role of HLA-DR2 and DR3 molecules, which have been associated with systemic lupus erythematosus, a humanized mouse model was examined. HLA-DR2 (DRB1*1502)- and DR3 (DRB1*0301)-transgenic mice were backcrossed to the New Zealand Mixed 2410 (NZM 2410, H2z) strain. Seventh generation DR2 and DR3 transgene-positive animals along with their transgene-negative littermates and the parental strain NZM2410 were monitored for proteinuria, azotemia, autoantibody production, development of nephritis, and mortality. The results showed no significant differences in proteinuria, azotemia, or mortality between the backcrosses with and without HLA-DR2 or HLA-DR3. However, the genetic analysis of different backcrosses showed that heterozygosity at the endogenous H2-E locus (Ez/Eb) was strongly linked with acceleration of lupus nephritis in both HLA-DR2 and HLA-DR3 transgenics. More importantly, the presence of the HLA-DR2, but not the HLA-DR3, transgene significantly enhanced the production of anti-dsDNA, but not anti-ssDNA, anti-histone-dsDNA complex, or anti-histone, Abs. In contrast, neither HLA-DR2 nor HLA-DR3 influenced the development of glomerulonephritis or the degree of immune complex deposition. Moreover, nephritic kidneys from mice with and without HLA-DR2 or HLA-DR3 transgenes showed similar patterns of cytokine expression. Collectively, these findings provide molecular evidence that the association of HLA-DR2 or HLA-DR3 with lupus susceptibility is related to the type of autoantibody rather than to disease mortality. The use of a humanized mouse model provides a way of dissecting the roles of human MHC genes in systemic lupus erythematosus pathogenesis.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
V. R. Chowdhary, J. P. Grande, H. S. Luthra, and C. S. David
Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus
Rheumatology, September 1, 2007; 46(9): 1405 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. T. McClain, C. S. Lutz, K. M. Kaufman, O. Z. Faig, T. F. Gross, and J. A. James
Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response
PNAS, March 9, 2004; 101(10): 3551 - 3556.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. Rajagopalan, Y. C. Kudva, L. Chen, L. Wen, and C. S. David
Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the {beta} cells of islets of Langerhans
Int. Immunol., September 1, 2003; 15(9): 1035 - 1044.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Taneja, N. Taneja, T. Paisansinsup, M. Behrens, M. Griffiths, H. Luthra, and C. S. David
CD4 and CD8 T Cells in Susceptibility/Protection to Collagen-Induced Arthritis in HLA-DQ8-Transgenic Mice: Implications for Rheumatoid Arthritis
J. Immunol., June 1, 2002; 168(11): 5867 - 5875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.